Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients
- PMID: 2566734
- DOI: 10.1016/s0140-6736(89)92749-9
Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients
Abstract
Six patients with chronic relapsing diarrhoea caused by Clostridium difficile were treated with rectal instillation of homologous faeces (one patient) or a mixture of ten different facultatively aerobic and anaerobic bacteria diluted in sterile saline (five patients). The mixture led to a prompt loss of Cl difficile and its toxin from the stools and to bowel colonisation by Bacteroides sp, which had not been present in pre-treatment stool samples. Strains of Escherichia coli, Cl bifermentans, and Peptostreptococcus productus in the mixture inhibited the in-vitro growth of Cl difficile, which in turn inhibited the growth of Bacteroides ovatus, Bacteroides vulgatus, and Bacteroides thetaiotaomicron. The finding that Bacteroides sp had been absent during the patients' illness but was present after recovery suggests that the absence of Bacteroides sp may result in chronic relapsing Cl difficile diarrhoea, and that its presence may prevent colonisation by Cl difficile.
Comment in
-
Bacteriotherapy for Clostridium difficile diarrhoea.Lancet. 1989 Sep 2;2(8662):558. doi: 10.1016/s0140-6736(89)90674-0. Lancet. 1989. PMID: 2570250 No abstract available.
-
Bacteriotherapy for clostridium difficile colitis.Lancet. 1989 Nov 4;2(8671):1096. doi: 10.1016/s0140-6736(89)91103-3. Lancet. 1989. PMID: 2572812 No abstract available.
Similar articles
-
Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012.Clin Microbiol Infect. 2015 Jan;21(1):48-53. doi: 10.1016/j.cmi.2014.07.003. Epub 2014 Oct 12. Clin Microbiol Infect. 2015. PMID: 25636927
-
Bacteriotherapy for Clostridium difficile diarrhoea.Lancet. 1989 Sep 2;2(8662):558. doi: 10.1016/s0140-6736(89)90674-0. Lancet. 1989. PMID: 2570250 No abstract available.
-
Clostridium difficile in association with sporadic diarrhoea.Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):230-3. doi: 10.1136/bmj.284.6311.230. Br Med J (Clin Res Ed). 1982. PMID: 6799113 Free PMC article.
-
Fecal bacteriotherapy for recurrent Clostridium difficile infection.Anaerobe. 2009 Dec;15(6):285-9. doi: 10.1016/j.anaerobe.2009.09.007. Epub 2009 Sep 22. Anaerobe. 2009. PMID: 19778623 Review.
-
Polymicrobial septicemia with Clostridium difficile in acute diverticulitis.Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):300-2. doi: 10.1007/BF01963455. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2497002 Review.
Cited by
-
Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):67-80. doi: 10.1038/s41575-020-0350-4. Epub 2020 Aug 25. Nat Rev Gastroenterol Hepatol. 2021. PMID: 32843743 Review.
-
Towards a deeper understanding of microbial communities: integrating experimental data with dynamic models.Curr Opin Microbiol. 2021 Aug;62:84-92. doi: 10.1016/j.mib.2021.05.003. Epub 2021 Jun 4. Curr Opin Microbiol. 2021. PMID: 34098512 Free PMC article. Review.
-
Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities.Microb Biotechnol. 2019 Jan;12(1):58-65. doi: 10.1111/1751-7915.13355. Microb Biotechnol. 2019. PMID: 30575298 Free PMC article.
-
Microbial community design: methods, applications, and opportunities.Curr Opin Biotechnol. 2019 Aug;58:117-128. doi: 10.1016/j.copbio.2019.03.002. Epub 2019 Apr 3. Curr Opin Biotechnol. 2019. PMID: 30952088 Free PMC article. Review.
-
Have enteric infections a role in 5-fluorouracil-associated diarrhea?Support Care Cancer. 1995 Sep;3(5):322-3. doi: 10.1007/BF00335311. Support Care Cancer. 1995. PMID: 8520881
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical